Advancing stem cell therapy to help those battling Duchenne Muscular Dystrophy and other rare diseases

Our Feature Documentary

We are always looking for new ways to grow our community and tell the stories of those affected by rare diseases. Currently, we are mid-production on a feature-length documentary focused not only on Ryan’s story, but also the stories of families worldwide that CTFAC has helped, and the work we’ve done to advocate for and advance stem cell therapy.

This is the best way to understand our full story, goals, and the drive behind our mission. We are currently still raising funds to finish this project, and all donations will be matched until it is finished.

Our Success with Stem Cell therapy

In 2008, our founder, Ryan Benton was 22 years old and reaching a critical stage in the progression of his terminal disease, Duchenne Muscular Dystrophy. With no viable treatment option available, we placed our last hope in Dr. Riordan’s offer to treat Ryan with Mesenchymal Stem Cell Therapy.  

Fortunately, the treatments worked, allowing him to produce dystrophin and reverse the progression of his disease for the first time ever. This made Ryan the first person with DMD to be successfully treated with stem cell therapy, paving the way for others. Over 14 years and 100+ treatments later, CTFAC helped give families around the world hope they could believe in.

Our Global Impact

We are based in Wichita, Kansas but we have created a worldwide community that has shared commonalities centered around one thing. Hope.

Globe Icon
Connecting with nearly 500 families across the globe
Treatment Icon
Helping over 150 families access treatments
Clinical Trial Icon
Launching Clinical trial(s) across the world

Keep Up With Coming Together For A Cure

After experiencing remarkable success with stem cell therapy, Ryan’s transformative journey created a ripple effect of inspiration, hope, and curiosity among others with rare diseases around the world. Through their shared stories, this community has become a network of support as we continue to push to make this kind of treatment accessible to everyone.

Dr. Riordan